Durable Response of Low-Dose Afatinib plus Cetuximab in an Adenocarcinoma Patient with a Novel EGFR Exon 20 Insertion Mutation

被引：13
|
作者：
Fang, Wenfeng [1 ]
Huang, Yihua [1 ]
Gan, Jiadi [1 ]
Shao, Yang W. [2 ]
Zhang, Li [1 ]
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[2] Nanjing Geneseeq Technol Inc, Nanjing, Jiangsu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
基金：
国家重点研发计划;
关键词：
D O I：
10.1016/j.jtho.2019.05.023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：E220 / E221
页数：2
相关论文
共 50 条
  • [21] Successful Salvage Therapy With a High Dose of Furmonertinib in a Case of Lung Adenocarcinoma Harboring EGFR Exon 20 Insertion
    Jiang, Weizhen
    Sha, Min
    Chen, Cheng
    AMERICAN JOURNAL OF THERAPEUTICS, 2023, 30 (06) : E571 - E573
  • [22] A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer
    van Veggel, Bianca A. M. H.
    van der Wekken, Anthonie J.
    Paats, Marthe S.
    Hendriks, Lizza E. L.
    Hashemi, Sayed M. S.
    Daletzakis, Antonios
    van den Broek, Daan
    Bosch, Linda J. W.
    Monkhorst, Kim
    Smit, Egbert F.
    de Langen, Adrianus J.
    CANCER, 2024, 130 (05) : 683 - 691
  • [23] Lung Adenocarcinoma Patient Harboring EGFR-KDD Achieve Durable Response to Afatinib: A Case Report and Literature Review
    Zhao, Lingling
    Wang, Zhen
    Du, Haiwei
    Chen, Songan
    Wang, Pingli
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib
    Yan Chen
    Bo Jiang
    Yuange He
    Chu Zhang
    Wenjie Zhou
    Cheng Fang
    Dejian Gu
    Minxia Zhang
    Mei Ji
    Juntao Shi
    Xin Yang
    BMC Medical Genomics, 15
  • [25] A lung adenocarcinoma patient with co-mutations of MET and EGFR exon20 insertion responded to crizotinib
    Chen, Yan
    Jiang, Bo
    He, Yuange
    Zhang, Chu
    Zhou, Wenjie
    Fang, Cheng
    Gu, Dejian
    Zhang, Minxia
    Ji, Mei
    Shi, Juntao
    Yang, Xin
    BMC MEDICAL GENOMICS, 2022, 15 (01)
  • [26] A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report
    Zhou, Tao
    Xiong, Qiang
    Hong, Chen
    Wang, Qian
    Wang, Wenxian
    Xu, Chunwei
    Cai, Jing
    MEDICINE, 2022, 101 (34) : E30269
  • [27] Case report: Durable response to afatinib in a patient with lung cancer harboring two uncommon mutations of EGFR and a KRAS mutation
    Tanizaki, Junko
    Banno, Eri
    Togashi, Yosuke
    Hayashi, Hidetoshi
    Sakai, Kazuko
    Takeda, Masayuki
    Kaneda, Hiroyasu
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    LUNG CANCER, 2016, 101 : 11 - 15
  • [28] Prognostic Impact of Exon20 Insertion in Surgically Resected Lung Adenocarcinoma Harboring Atypical EGFR Single Mutation
    Chen, T.
    Zhong, Y.
    Wen, J.
    Deng, J.
    She, Y.
    Chen, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S277 - S277
  • [29] Severe Psychiatric Symptoms in a Patient With EGFR Exon-20 Insertion Mutation Receiving Mobocertinib: A Case Report
    Kamel, Josette
    Meeder, Natalie
    Cuellar, Sandra
    Chan, David
    Huber, Michael
    Pasquinelli, Mary
    Hulbert, Alicia
    Khaddour, Karam
    Feldman, Lawrence
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (11):
  • [30] Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab
    Motohiro Tamiya
    Kei Kunimasa
    Kazumi Nishino
    Shingo Matsumoto
    Hayato Kawachi
    Kika Kuno
    Takako Inoue
    Hanako Kuhara
    Fumio Imamura
    Koichi Goto
    Toru Kumagai
    Investigational New Drugs, 2021, 39 : 232 - 236
12345